UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 10, 2024 4:30 P.M.

Form:	S-3
CIK: 0001678660 Company Name: Prelude Therapeutics Inc File Number: 333-279829